Back to results
US 10,207,999 B2Granted
Inhibitors of lysine specific demethylase-1
AssigneeCelgene Quanticel Research, Inc.
InventorsYoung K. Chen, Toufike Kanouni, Stephen W. Kaldor, Jeffrey Alan Stafford, James Marvin Veal
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
Claims2
A compound, or pharmaceutically acceptable salt thereof, chosen from:
Dependencies are inferred from the claim text.